Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO GuidelineLarissa A. Korde, Dawn L. Hershman, Neelima Denduluri et al.|Journal of Clinical Oncology|2021Cited by 991
FOXA1 and adaptive response determinants to HER2 targeted therapy in TBCRC 036Steven P. Angus, Gary L. Johnson, Timothy J. Stuhlmiller et al.|npj Breast Cancer|2021Cited by 24